Heidi B Capozzi
CIK 1661608 · View on SEC EDGAR ↗
First SEC filing: Oct. 14, 2025 · Latest: April 2, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 23, 2024 | CVS | P | 35 | $56.85 | $1,990 | 85 Indirect | +70.00% | Acquired | 68.2% (price as of 2026-08-19) |
| Oct. 2, 2024 | CVS | P | 10 | $62.24 | $622 | 50 Indirect | +25.00% | Acquired | 53.6% (price as of 2026-08-19) |
| Sept. 9, 2024 | CVS | P | 35 | $56.47 | $1,976 | 40 Indirect | +700.00% | Acquired | 69.3% (price as of 2026-08-19) |
| Dec. 29, 2023 | MCD | S | 2,750 | $295.84 | $813,560 | 15,207 Direct | -15.31% | Disposed | -8.3% (price as of 2026-08-19) |
| Dec. 1, 2023 | MCD | S | 687 | $283.25 | $194,593 | 17,957 Direct | -3.68% | Disposed | -4.2% (price as of 2026-08-19) |
| Nov. 1, 2023 | MCD | S | 687 | $263.00 | $180,681 | 18,644 Direct | -3.55% | Disposed | 3.2% (price as of 2026-08-19) |
| Oct. 2, 2023 | MCD | S | 688 | $262.00 | $180,256 | 19,331 Direct | -3.44% | Disposed | 3.6% (price as of 2026-08-19) |
| Sept. 1, 2023 | MCD | S | 688 | $282.54 | $194,388 | 20,019 Direct | -3.32% | Disposed | -4.0% (price as of 2026-08-19) |
| Feb. 13, 2019 | BA | S | 2,916 | $410.84 | $1,198,009 | 24,791 Direct | -10.52% | Disposed | -46.1% (price as of 2026-08-19) |
| May 3, 2018 | BA | S | 1,132 | $329.84 | $373,379 | 24,416 Direct | -4.43% | Disposed | -32.8% (price as of 2026-08-19) |
| Aug. 1, 2017 | BA | S | 2,871 | $240.95 | $691,767 | 23,582 Direct | -10.85% | Disposed | -8.0% (price as of 2026-08-19) |
| July 31, 2017 | BA | S | 1,346 | $242.72 | $326,701 | 26,453 Direct | -4.84% | Disposed | -8.7% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 31, 2026 | CVS | Stock Option [F3] | Common Stock (64,670) | $71.82 | March 31, 2036 | 64,670 | Acquired |
| April 1, 2025 | CVS | Stock Option [F2] | Common Stock (49,906) | $67.98 | April 1, 2035 | 49,906 | Acquired |
| May 28, 2024 | MCD | Dividend Equivalent Rights | Common Stock | — | May 28, 2024 | 630 | Disposed |
| May 28, 2024 | MCD | Restricted Stock Units | Common Stock | — | May 28, 2024 | 6,623 | Disposed |
| Feb. 16, 2024 | MCD | Dividend Equivalent Rights | Common Stock | — | Feb. 16, 2024 | 894 | Disposed |
| Feb. 16, 2024 | MCD | Restricted Stock Units | Common Stock | — | Feb. 16, 2024 | 12,956 | Disposed |
| Feb. 12, 2024 | MCD | Restricted Stock Units | Common Stock | — | Feb. 16, 2024 | 6,940 | Acquired |
| Feb. 12, 2024 | MCD | Options (Right to Buy) | Common Stock (25,076) | $289.44 | Feb. 12, 2034 | 25,076 | Acquired |
| May 28, 2023 | MCD | Dividend Equivalent Rights | Common Stock | — | May 28, 2023 | 513 | Disposed |
| May 28, 2023 | MCD | Restricted Stock Units | Common Stock | — | May 28, 2023 | 7,241 | Disposed |
| Feb. 13, 2019 | BA | Stock Option (Right to Buy) | Common Stock (2,916) | $75.96 | Feb. 25, 2023 | 2,916 | Disposed |
| July 31, 2017 | BA | Stock Option (Right to Buy) | Common Stock (1,346) | $75.40 | Feb. 27, 2022 | 1,346 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 14, 2025 | CVS | Common Stock | — | Indirect |
| Dec. 22, 2015 | BA | Common Stock | — | Direct |
| Dec. 22, 2015 | BA | Common Stock | 112 | Indirect |
| Dec. 22, 2015 | BA | Stock Option (Right to Buy)→ Common Stock (1,346) | 1,346 | Direct |
| Dec. 22, 2015 | BA | Stock Option (Right to Buy)→ Common Stock (2,916) | 2,916 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CVS
Chief People Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $265,625 | $1,500,000 | — | — | — | — | $85,134 | $6,850,748 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.